Kingworld Medicines Group Limited

Informe acción SEHK:1110

Capitalización de mercado: HK$252.1m

Kingworld Medicines Group Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Li Sheng Zhao

Chief Executive Officer (CEO)

CN¥1.5m

Compensación total

Porcentaje del salario del CEO98.5%
Permanencia del CEO16.2yrs
Participación del CEO54.3%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva14yrs

Actualizaciones recientes de la dirección

Recent updates

The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence

Nov 13
The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence

Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Oct 04
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

May 31
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

May 22
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Apr 29
Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Apr 23
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Mar 22
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Nov 30
The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Aug 17
Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

May 30
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

May 11
The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Apr 03
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

Feb 07
Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Oct 07
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Jul 05
Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

Apr 27
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Aug 17
We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Apr 24
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Mar 29
Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Mar 08
Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Feb 15
Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Jan 25
Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

Dec 18
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

Dec 05
We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Nov 22
What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Li Sheng Zhao en comparación con los beneficios de Kingworld Medicines Group?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2024n/an/a

CN¥31m

Mar 31 2024n/an/a

CN¥35m

Dec 31 2023CN¥1mCN¥1m

CN¥38m

Sep 30 2023n/an/a

CN¥37m

Jun 30 2023n/an/a

CN¥36m

Mar 31 2023n/an/a

CN¥29m

Dec 31 2022CN¥1mCN¥1m

CN¥23m

Sep 30 2022n/an/a

CN¥29m

Jun 30 2022n/an/a

CN¥35m

Mar 31 2022n/an/a

CN¥33m

Dec 31 2021CN¥1mCN¥1m

CN¥30m

Sep 30 2021n/an/a

CN¥26m

Jun 30 2021n/an/a

CN¥21m

Mar 31 2021n/an/a

CN¥17m

Dec 31 2020CN¥1mCN¥1m

CN¥12m

Sep 30 2020n/an/a

CN¥16m

Jun 30 2020n/an/a

CN¥20m

Mar 31 2020n/an/a

CN¥32m

Dec 31 2019CN¥2mCN¥2m

CN¥43m

Sep 30 2019n/an/a

CN¥45m

Jun 30 2019n/an/a

CN¥46m

Mar 31 2019n/an/a

CN¥44m

Dec 31 2018CN¥1mCN¥1m

CN¥41m

Sep 30 2018n/an/a

CN¥49m

Jun 30 2018n/an/a

CN¥56m

Mar 31 2018n/an/a

CN¥54m

Dec 31 2017CN¥2mCN¥1m

CN¥51m

Compensación vs. Mercado: La compensación total ($USD200.40K) de Li Sheng está en línea con el promedio de empresas de tamaño similar en el mercado Hong Kong ($USD233.11K).

Compensación vs. Ingresos: La compensación de Li Sheng ha sido consistente con los resultados de la empresa en el último año.


CEO

Li Sheng Zhao (66 yo)

16.2yrs

Permanencia

CN¥1,452,000

Compensación

Mr. Li Sheng Zhao is a Co-founder of Kingworld Medicines Group Limited and serves as its Chief Executive Officer. Mr. Zhao is responsible for Kingworld Medicines Group's overall strategic planning and busi...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Li Sheng Zhao
Co-Founder16.2yrsCN¥1.45m54.31%
HK$ 136.9m
Lok San Chan
Co-Founder & Executive Director16.2yrsCN¥1.32m15.18%
HK$ 38.3m
Xuhua Zhou
Executive Director15.3yrsCN¥483.00k0.45%
HK$ 1.1m
Cheuk Lam Wong
Independent Non-Executive Director14yrsCN¥285.00k0.036%
HK$ 90.1k
Jidong Duan
Independent Non-Executive Director14yrsCN¥285.00ksin datos
Jianbin Zhang
Independent Non-Executive Director11.3yrsCN¥285.00k0.042%
HK$ 105.4k
Xiaoping Chu
Independent Non-Executive Directorless than a yearsin datossin datos

14.0yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de 1110 son experimentados ( 14 años antigüedad media).